Big news for cancer care! The FDA just approved Guardant Health’s Guardant360 CDx blood test to help guide treatment for advanced colorectal cancer. This is the first liquid biopsy of its kind, letting doctors use a simple blood draw to spot key mutations and match patients to targeted therapies faster—no more waiting for tissue samples. Plus, Guardant Health’s stock is on fire, hitting new highs after the announcement! #Health #BodyHealth #CancerCare